Mochi Health vs NovoCare Pharmacy (Wegovy) (2026): prices, structure, verdict

On tirzepatide, only Mochi Health↗ has a rankable figure: $278 a month all-in; NovoCare Pharmacy (Wegovy)↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Mochi Health is cheaper: $178 versus $349 a month all-in — a $171 monthly gap, $2,052 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Mochi Health: the record, condensed

On tirzepatide, the number that matters at Mochi Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Inside that $278 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $199, and it is not a price anyone can actually pay, because the membership cannot be declined.

To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

Mochi Health’s semaglutide program bills $178 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

A required $79/month membership is part of the deal, and part of the figure above: $99 of medication plus $79 of platform equals the $178 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

NovoCare Pharmacy (Wegovy): the record, condensed

NovoCare Pharmacy (Wegovy)’s semaglutide program bills $349 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes NovoCare Pharmacy (Wegovy) unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #0 of 20 in the verified semaglutide index — $216/month above the floor (Oak Longevity, $133) — and sits $0 over the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $4,188.

Operationally at NovoCare Pharmacy (Wegovy): shipping included (or retail via savings card); commitment none; cancellation no subscription; pharmacy named (Novo Nordisk direct / retail partners); states: 50 states; evidence source-verified, captured 2026-08-10. The full record with source and archive links: the NovoCare Pharmacy (Wegovy) page · visit NovoCare Pharmacy (Wegovy) ↗

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $178 (Mochi Health) against $349 (NovoCare Pharmacy (Wegovy)). $171 a month sounds survivable; $2,052 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $171 gap is exactly what it appears to be.

Mochi Health’s total includes a mandatory $79/month membership; NovoCare Pharmacy (Wegovy) has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

A way to feel the $171 monthly gap: over a year it funds 11.5 extra months at Mochi Health’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $4,104, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Mochi Health $178/mo month-to-month against NovoCare Pharmacy (Wegovy) $349/mo month-to-month. The order holds: Mochi Health leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Mochi Health $534 monthly; NovoCare Pharmacy (Wegovy) $1,047 monthly — best path favors Mochi Health by $513. 6 months: Mochi Health $1,068 monthly; NovoCare Pharmacy (Wegovy) $2,094 monthly — best path favors Mochi Health by $1,026. 12 months: Mochi Health $2,136 monthly; NovoCare Pharmacy (Wegovy) $4,188 monthly — best path favors Mochi Health by $2,052. 24 months: Mochi Health $4,272 monthly; NovoCare Pharmacy (Wegovy) $8,376 monthly — best path favors Mochi Health by $4,104.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Mochi Health publishes “most states”; NovoCare Pharmacy (Wegovy) publishes “50 states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency: both name fulfillment (company-owned compounding facility / Novo Nordisk direct / retail partners) — rare in this market, and it makes both independently checkable.

Exit terms: Mochi Health — membership recurs monthly; cancel membership any time; recurs until cancelled. NovoCare Pharmacy (Wegovy) — none; no subscription.

Evidence: Mochi Health source-verified (captured 2026-08-05); NovoCare Pharmacy (Wegovy) source-verified (2026-08-10).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

§ If you move

Switching between Mochi Health and NovoCare Pharmacy (Wegovy)

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Mochi Health: cancel membership any time; recurs until cancelled; NovoCare Pharmacy (Wegovy): no subscription) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings